Chemical Compound

N-Monodemethylaclacinomycin A

CAS Registry Number 64431-58-9
Back to search Request a Quote
N-Monodemethylaclacinomycin A chemical structure
Primary Record

N-Monodemethylaclacinomycin A

In stock
1,759 g
Purity
98.4 %
CAS
64431-58-9

Compound Identifiers & Properties

CAS
64431-58-9
PubChem CID
150200
SMILES
CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)NC)O
Canonical SMILES
CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC

Names & Synonyms

  • N-Monodemethylaclacinomycin A
  • Antibiotic MA 144L1
  • N-Demethylaclacinomycin A
  • UNII-R992SD6O2C
  • Antibiotic MA-144L1
  • MA 144L1
  • RefChem:199606
  • R992SD6O2C
  • MA-144L1
  • DTXSID00214685
  • AC1L43V6
  • DTXCID30137176
  • C41H51NO15
  • CID150200
  • C41-H51-N-O15
  • LS-93945
  • J153.920E
  • 64431-58-9
  • Q27288001
  • 1-Naphthacenecarboxylic acid, 1,2,3,4,6,11-hexahydro-6,11-dioxo-2-ethyl-4-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(methylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-2,5,7-trihydroxy-, methyl ester, (1R-(1-alpha,2-beta,4-beta))-
  • 1-NAPHTHACENECARBOXYLIC ACID, 2-ETHYL-1,2,3,4,6,11-HEXAHYDRO-2,5,7-TRIHYDROXY-6,11-DIOXO-4-((2,3,6-TRIDEOXY-4-O-(2,6-DIDEOXY-4-O-((2R,6S)-TETRAHYDRO-6-METHYL-5-OXO-2H-PYRAN-2-YL)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)-3-(METHYLAMINO)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-, METHYL ESTER, (1R,2R,4S)-
  • 1-NAPHTHACENECARBOXYLIC ACID, 2-ETHYL-1,2,3,4,6,11-HEXAHYDRO-2,5,7-TRIHYDROXY-6,11-DIOXO-4-((2,3,6-TRIDEOXY-4-O-(2,6-DIDEOXY-4-O-((2R-TRANS)-TETRAHYDRO-6-METHYL-5-OXO-2H-PYRAN-2-YL)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)-3-(METHYLAMINO)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-, METHYL ESTER, (1R-(1.ALPHA.,2.BETA.,4.BETA.))-
  • (1R)-1,2,3,4,6,11-Hexahydro-6,11-dioxo-2-ethyl-4alpha-[[4-O-[4-O-[(2R)-tetrahydro-6alpha-methyl-5-oxo-2H-pyran-2beta-yl]-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl]-3-(methylamino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl]oxy]-2alpha,5,7-trihydroxy-1beta-naphthacenecarboxylic acid methyl ester
  • 1-NAPHTHACENECARBOXYLIC ACID, 2-ETHYL-1,2,3,4,6,11-HEXAHYDRO-2,5,7-TRIHYDROXY-6,11-DIOXO-4-((2,3,6-TRIDEOXY-4-O-(2,6-DIDEOXY-4-O-((2R,6S)-TETRAHYDRO-6-METHYL-5-OXO-2H-PYRAN-2-YL)-ALPHA-L-LYXO-HEXOPYRANOSYL)-3-(METHYLAMINO)-ALPHA-L-LYXO-HEXOPYRANOSYL)OXY)-, METHYL ESTER, (1R,2R,4S)-
  • 1-NAPHTHACENECARBOXYLIC ACID, 2-ETHYL-1,2,3,4,6,11-HEXAHYDRO-2,5,7-TRIHYDROXY-6,11-DIOXO-4-((2,3,6-TRIDEOXY-4-O-(2,6-DIDEOXY-4-O-((2R-TRANS)-TETRAHYDRO-6-METHYL-5-OXO-2H-PYRAN-2-YL)-ALPHA-L-LYXO-HEXOPYRANOSYL)-3-(METHYLAMINO)-ALPHA-L-LYXO-HEXOPYRANOSYL)OXY)-, METHYL ESTER, (1R-(1ALPHA,2BETA,4BETA))-
  • 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-.alpha.-L-lyxo-hexopyranosyl]-3-(methylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-, methyl ester, [1R-(1.alpha.,2.beta.,4.beta.)]-
  • methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-4-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-4-hydroxy-6-methyl-5-[(2R,6S)-6-methyl-5-oxooxan-2-yl]oxyoxan-2-yl]oxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate
  • methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-4-{[(2R,4S,5S,6S)-5-{[(2S,4S,5S,6S)-4-hydroxy-6-methyl-5-{[(2R,6S)-6-methyl-5-oxooxan-2-yl]oxy}oxan-2-yl]oxy}-6-methyl-4-(methylamino)oxan-2-yl]oxy}-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
  • Methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxooxan-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(methylamino)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate